Helsinn Healthcare SA

Helsinn is a Swiss-based Group, focusing on developing and licensing innovative and valuable pharmaceutical compounds up to the highest quality standards.

Helsinn differs from other pharmaceutical groups since it acquires the global rights to new compounds when these are at the early clinical stage of development. It then completes their development up to the European (EMA) and the U.S. (FDA) standards and subsequently markets the products through its established network of partners in more than 75 countries.

Our manufacturing plants located in Switzerland and Ireland provide the development and manufacturing of Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, High Potency Active Ingredients (HPAIs) and Drug Product for our partners and also for third parties.

The company within the Group which co-ordinates and manages all activities is Helsinn Healthcare SA, based in Lugano (Switzerland). The manufacturing sites are Helsinn Advanced Synthesis SA based in Biasca (Switzerland) and Helsinn Birex Pharmaceutical Ltd. based in Damastown (Ireland).

The Group acquired a US-based biotech company  and established Helsinn Therapeutics (U.S.) Inc. with headquarters in Iselin, New Jersey, which is focused on direct sale of Helsinn products in the USA. Helsinn Group is present in China with the company Helsinn Pharmaceuticals (Beijing) Co. Ltd. and has offices in Beijing and in Shanghai.

If you would like to send your application to the Helsinn Group Companies , please complete the form you will find at the following link: helsinn.jobopportunity.ch

Please note that by clicking this link you will be re-directed to a website hosted by a third party and in respect of which Helsinn has no control. In turn, you will be subject to the privacy policy of this third party which is available here: